( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

50 publications found

Warning: limit reached; process these papers and then reload to see if there are more for this author name string
Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Matched potential author: Yaoxing Huang - author of 8 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain[1]Gabriele Cerutti, [2]Yicheng Guo, [3]Pengfei Wang, [4]Manoj S Nair, [5]Maple Wang, [6]Yaoxing Huang, [7]Jian Yu, [8]Lihong Liu, [9]Phinikoula S Katsamba, [10]Fabiana Bahna, [11]Eswar R Reddem, [12]Peter D Kwong, [13]David D Ho, [14]Zizhang Sheng, [15]Lawrence Shapiro [Full author list]Cell Reports [missing]DOI: 10.1016/J.CELREP.2021.109928 [ORCID]
PubMed: 34706271 [ORCID]
NTD [missing]; neutralizing antibody [missing]; Cryo-EM [missing]; SARS-CoV-2 [missing]; variant of concern [missing]2021-11-02Yaoxing Huang (Q97650828; 8 items)
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses[1]Bailey B Banach, [2]Gabriele Cerutti, [3]Ahmed S Fahad, [4]Chen-Hsiang Shen, [5]Matheus Oliveira De Souza, [6]Phinikoula S Katsamba, [7]Yaroslav Tsybovsky, [8]Pengfei Wang, [9]Manoj S Nair, [10]Yaoxing Huang, [11]Irene M Francino-Urdániz, [12]Paul J Steiner, ... [Full author list]Cell Reports [missing]DOI: 10.1016/J.CELREP.2021.109771 [ORCID]
PubMed: 34587480 [ORCID]
B-cell [missing]; Yeast display [missing]; SARS-CoV-2 [missing]2021-10-05Yaoxing Huang (Q97650828; 8 items)
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies[1]Gabriele Cerutti, [2]Micah Rapp, [3]Yicheng Guo, [4]Fabiana Bahna, [5]Jude Bimela, [6]Eswar R Reddem, [7]Jian Yu, [8]Pengfei Wang, [9]Lihong Liu, [10]Yaoxing Huang, [11]David D Ho, [12]Peter D Kwong, [13]Zizhang Sheng, [14]Lawrence Shapiro [Full author list]Structure [missing]DOI: 10.1016/J.STR.2021.05.014 [ORCID]
PubMed: 34111408 [ORCID]
neutralizing antibody [missing]; Cryo-EM [missing]; SARS-CoV-2 [missing]; SARS-CoV-2 Alpha variant [missing]; SARS-CoV-2 Beta variant [missing]; Lineage B.1.1.7 with E484K [missing]2021-07-01Yaoxing Huang (Q97650828; 8 items)
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class[1]Micah Rapp, [2]Yicheng Guo, [3]Eswar R Reddem, [4]Jian Yu, [5]Lihong Liu, [6]Pengfei Wang, [7]Gabriele Cerutti, [8]Phinikoula Katsamba, [9]Jude S Bimela, [10]Fabiana A Bahna, [11]Seetha M Mannepalli, [12]Baoshan Zhang, [13]Peter D Kwong, [14]Yaoxing Huang, [15]David D Ho, [16]Lawrence Shapiro, [17]Zizhang Sheng [Full author list]Cell Reports [missing]DOI: 10.1016/J.CELREP.2021.108950 [ORCID]
PubMed: 33794145 [ORCID]
neutralizing antibody [missing]; SARS-CoV-2 [missing]2021-04-06Yaoxing Huang (Q97650828; 8 items)
The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8[1]Miklos Guttman, [2]Neal N Padte, [3]Yaoxing Huang, [4]Jian Yu, [5]Gabriel J Rocklin, [6]Brian D Weitzner, [7]Michele Scian, [8]David D Ho, [9]Kelly K Lee [Full author list]Scientific Reports [missing]DOI: 10.1038/S41598-020-71184-7 [ORCID]
PubMed: 32868832 [ORCID]
2020-08-31
In Vivo Expressed Biologics for Infectious Disease Prophylaxis: Rapid Delivery of DNA-Based Antiviral Antibodies[1]Chasity D Andrews, [2]Yaoxing Huang, [3]David D Ho, [4]Rachel A Liberatore [Full author list]Emerging Microbes & Infections [missing]DOI: 10.1080/22221751.2020.1787108 [ORCID]
PubMed: 32579067 [ORCID]
infectious disease [missing]2020-06-24
Engineering multi-specific antibodies against HIV-1[1]Neal N Padte, [2]Jian Yu, [3]Yaoxing Huang, [4]David D Ho [Full author list]Retrovirology [missing]DOI: 10.1186/S12977-018-0439-9 [ORCID]
PubMed: 30157871 [ORCID]
virus [missing]; virology [missing]; globulins [missing]; blood proteins [missing]; neutralizing antibody [missing]; infectious disease [missing]; human immunodeficiency virus infectious disease [missing]; RNA virus infectious disease [missing]; Retroviridae infectious disease [missing]; biomedical investigative technique [missing]2018-08-29
DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers[1]Madhura Mukhopadhyay, [2]Moran Galperin, [3]Mandar Patgaonkar, [4]Sandhya Vasan, [5]David D Ho, [6]Alexandre Nouël, [7]Mathieu Claireaux, [8]Daniela Benati, [9]Olivier Lambotte, [10]Yaoxing Huang, [11]Lisa A Chakrabarti [Full author list]Journal of Immunology [missing]DOI: 10.4049/JIMMUNOL.1700953 [ORCID]
PubMed: 28993513 [ORCID]
electroporation [missing]2017-10-09
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections[1]Chasity D Andrews, [2]Yang Luo, [3]Ming Sun, [4]Jian Yu, [5]Arthur J Goff, [6]Pamela J Glass, [7]Neal N Padte, [8]Yaoxing Huang, [9]David D Ho [Full author list]Molecular Therapy. Methods & Clinical Development [missing]DOI: 10.1016/J.OMTM.2017.09.003 [ORCID]
PubMed: 29034261 [ORCID]
electroporation [missing]; Orthoebolavirus zairense [missing]2017-09-20Yaoxing Huang (Q97650828; 8 items)
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity[1]Yaoxing Huang, [2]Jian Yu, [3]Anastasia Lanzi, [4]Xin Yao, [5]Chasity D Andrews, [6]Lily Tsai, [7]Mili R Gajjar, [8]Ming Sun, [9]Michael S Seaman, [10]Neal N Padte, [11]David D Ho [Full author list]Cell [missing]DOI: 10.1016/J.CELL.2016.05.024 [ORCID]
PubMed: 27315479 [ORCID]
antibody [missing]2016-06-01
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36.[1]Ming Sun, [2]Craig S Pace, [3]Xin Yao, [4]Faye Yu, [5]Neal N Padte, [6]Yaoxing Huang, [7]Michael S Seaman, [8]Qihan Li, [9]David D Ho [Full author list]Journal of Acquired Immune Deficiency Syndromes [missing]DOI: 10.1097/QAI.0000000000000218 [ORCID]
PubMed: 24853313 [ORCID]
antibody [missing]2014-08-01
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse mo[1]Chandrabali Ghose, [2]Janneke M Verhagen, [3]Xinhua Chen, [4]Jian Yu, [5]Yaoxing Huang, [6]Olivia Chenesseau, [7]Ciarán P Kelly, [8]David D Ho [Full author list]Infection and Immunity [missing]DOI: 10.1128/IAI.01074-12 [ORCID]
PubMed: 23545305 [ORCID]
Clostridium difficile [missing]; toll-like receptor [missing]; Salmonella enterica [missing]2013-04-01
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice[1]Gerasimos J Zaharatos, [2]Jian Yu, [3]Craig Pace, [4]Yang Song, [5]Sandhya Vasan, [6]David D Ho, [7]Yaoxing Huang [Full author list]Vaccine [missing]DOI: 10.1016/J.VACCINE.2011.10.056 [ORCID]
PubMed: 22064264 [ORCID]
2011-11-04
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.[1]Juliana Idoyaga, [2]Ashira Lubkin, [3]Christopher Fiorese, [4]Mireille H. Lahoud, [5]Irina Caminschi, [6]Yaoxing Huang, [7]Anthony Rodriguez, [8]Björn E Clausen, [9]Chae Gyu Park, [10]Christine Trumpfheller, [11]Ralph Steinman [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.1019547108 [ORCID]
PubMed: 21262813 [ORCID]
antibody [missing]; dendritic cell [missing]2011-01-24
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers[1]Sandhya Vasan, [2]Arlene Hurley, [3]Sarah J Schlesinger, [4]Drew Hannaman, [5]David F Gardiner, [6]Daniel P Dugin, [7]Mar Boente-Carrera, [8]Roselle Vittorino, [9]Marina Caskey, [10]Johanne Andersen, [11]Yaoxing Huang, [12]Josephine H Cox, [13]Tony Tarragona-Fiol, ... [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0019252 [ORCID]
PubMed: 21603651 [ORCID]
vaccine [missing]; electroporation [missing]2011-01-01
Epitope mapping of ibalizumab, a humanized anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patients[1]Ruijiang Song, [2]David Franco, [3]Chia-Ying Kao, [4]Faye Yu, [5]Yaoxing Huang, [6]David D Ho [Full author list]Journal of Virology [missing]DOI: 10.1128/JVI.00453-10 [ORCID]
PubMed: 20463063 [ORCID]
antibody [missing]2010-05-12
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine[1]Sandhya Vasan, [2]Sarah J Schlesinger, [3]Zhiwei Chen, [4]Arlene Hurley, [5]Angela Lombardo, [6]Soe Than, [7]Phumla Adesanya, [8]Catherine Bunce, [9]Mark Boaz, [10]Rosanne Boyle, ..., [16]Qing Fang, [17]LeiBa, [18]Yaoxing Huang, [19]Gerasimos J Zaharatos, [20]David F Gardiner, ... [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0008816 [ORCID]
PubMed: 20111599 [ORCID]
2010-01-25
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine[1]Sandhya Vasan, [2]Sarah J Schlesinger, [3]Yaoxing Huang, [4]Arlene Hurley, [5]Angela Lombardo, [6]Zhiwei Chen, [7]Soe Than, [8]Phumla Adesanya, [9]Catherine Bunce, [10]Mark Boaz, ... [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0008617 [ORCID]
PubMed: 20111582 [ORCID]
2010-01-25
HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC[1]Leonia Bozzacco, [2]Christine Trumpfheller, [3]Yaoxing Huang, [4]Maria Paula Longhi, [5]Irina Shimeliovich, [6]Joseph D Schauer, [7]Chae Gyu Park, [8]Ralph Steinman [Full author list]European Journal of Immunology [missing]DOI: 10.1002/EJI.200939748 [ORCID]
PubMed: 19830741 [ORCID]
antibody [missing]2010-01-01
A recoding method to improve the humoral immune response to an HIV DNA vaccine[1]Yaoxing Huang, [2]Michael Krasnitz, [3]Raúl Rabadán, [4]Daniela Witten, [5]Yang Song, [6]Arnold J Levine, [7]David D Ho, [8]Harlan Robins [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0003214 [ORCID]
PubMed: 18791646 [ORCID]
2008-09-15
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells[1]Godwin Nchinda, [2]Janelle Kuroiwa, [3]Margarita Oks, [4]Christine Trumpfheller, [5]Chae Gyu Park, [6]Yaoxing Huang, [7]Drew Hannaman, [8]Sarah J Schlesinger, [9]Olga Mizenina, [10]Michel C. Nussenzweig, [11]Klaus Überla, [12]Ralph Steinman [Full author list]Journal of Clinical Investigation [missing]DOI: 10.1172/JCI34224 [ORCID]
PubMed: 18324335 [ORCID]
dendritic cell [missing]2008-04-01Yaoxing Huang (Q97650828; 8 items)
Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.[1]Yaoxing Huang, [2]Zhiwei Chen, [3]Wenyong Zhang, [4]Deborah Gurner, [5]Yang Song, [6]David F Gardiner, [7]David D Ho [Full author list]Journal of Acquired Immune Deficiency Syndromes [missing]DOI: 10.1097/QAI.0B013E3181651B9D [ORCID]
PubMed: 18209683 [ORCID]
vaccine engineering [missing]; DNA design [missing]2008-04-01
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide[1]Yaoxing Huang, [2]Alex Chen, [3]Xiangming Li, [4]Zhiwei Chen, [5]Wenyong Zhang, [6]Yang Song, [7]Deborah Gurner, [8]David Gardiner, [9]Sankha Basu, [10]David D Ho, [11]Moriya Tsuji [Full author list]Vaccine [missing]DOI: 10.1016/J.VACCINE.2008.02.002 [ORCID]
PubMed: 18329757 [ORCID]
vaccine [missing]2008-02-20Yaoxing Huang (Q97650828; 8 items)
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine[1]Christine Trumpfheller, [2]Marina Caskey, [3]Godwin Nchinda, [4]Maria Paula Longhi, [5]Olga Mizenina, [6]Yaoxing Huang, [7]Sarah J Schlesinger, [8]Marco Colonna, [9]Ralph Steinman [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.0711976105 [ORCID]
PubMed: 18256187 [ORCID]
vaccine [missing]; dendritic cell [missing]2008-02-06
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine[1]Christine Trumpfheller, [2]Jennifer S Finke, [3]Carolina B López, [4]Thomas M Moran, [5]Bruno Moltedo, [6]Helena Soares, [7]Yaoxing Huang, [8]Sarah J Schlesinger, [9]Chae Gyu Park, [10]Michel C Nussenzweig, [11]Angela Granelli-Piperno, [12]Ralph Steinman [Full author list]Journal of Experimental Medicine [missing]DOI: 10.1084/JEM.20052005 [ORCID]
PubMed: 16505141 [ORCID]
antibody [missing]; vaccine [missing]; dendritic cell [missing]2006-02-27
The HIV-1 vaccine race[1]David D Ho, [2]Yaoxing Huang [Full author list]Cell [missing]DOI: 10.1016/S0092-8674(02)00832-2 [ORCID]
PubMed: 12150921 [ORCID]
vaccine [missing]2002-07-01
CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV).[1]Zhiwei Chen, [2]Xiuqing Zhao, [3]Yaoxing Huang, [4]Agegnehu Gettie, [5]Lei Ba, [6]James Blanchard, [7]David D Ho [Full author list]Journal of Acquired Immune Deficiency Syndromes [missing]DOI: 10.1097/00042560-200206010-00001 [ORCID]
PubMed: 12045675 [ORCID]
2002-06-01

Group #2

Matched potential author: Yaoxing Huang - author of 8 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization[1]Pengfei Wang, [2]Ryan G Casner, [3]Manoj S Nair, [4]Maple Wang, [5]Jian Yu, [6]Gabriele Cerutti, [7]Lihong Liu, [8]Peter D. Kwong, [9]Yaoxing Huang, [10]Lawrence Shapiro, [11]David D Ho [Full author list]Cell Host & Microbe [missing]DOI: 10.1016/J.CHOM.2021.04.007 [ORCID]
PubMed: 33887205 [ORCID]
P.1 [missing]; SARS-CoV-2 [missing]; convalescent plasma [missing]2021-05-12Yaoxing Huang (Q97650828; 8 items)
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite[1]Gabriele Cerutti, [2]Yicheng Guo, [3]Tongqing Zhou, [4]Jason Gorman, [5]Myungjin Lee, [6]Micah Rapp, [7]Eswar R. Reddem, [8]Jian Yu, [9]Fabiana Bahna, [10]Jude Bimela, [11]Yaoxing Huang, [12]Phinikoula S. Katsamba, [13]Lihong Liu, ... [Full author list]Cell Host & Microbe [missing]DOI: 10.1016/J.CHOM.2021.03.005 [ORCID]
PubMed: 33789084 [ORCID]
SARS-CoV-2 [missing]2021-05-01Yaoxing Huang (Q97650828; 8 items)
A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York[1]Medini K Annavajhala, [2]Hiroshi Mohri, [3]Pengfei Wang, [4]Manoj Nair, [5]Jason E Zucker, [6]Zizhang Sheng, [7]Angela Gomez-Simmonds, [8]Anne L Kelley, [9]Maya Tagliavia, [10]Yaoxing Huang, [11]Trevor Bedford, [12]David D Ho, [13]Anne-Catrin Uhlemann [Full author list]DOI: 10.1101/2021.02.23.21252259 [ORCID]
PubMed: 33655278 [ORCID]
SARS-CoV-2 [missing]; SARS-CoV-2 Iota variant [missing]2021-02-25Yaoxing Huang (Q97650828; 8 items)
Structural Basis for Accommodation of Emerging B.1.351 and B.1.1.7 Variants by Two Potent SARS-CoV-2 Neutralizing Antibodies[1]Gabriele Cerutti, [2]Micah Rapp, [3]Yicheng Guo, [4]Fabiana Bahna, [5]Jude Bimela, [6]Eswar R Reddem, [7]Jian Yu, [8]Pengfei Wang, [9]Lihong Liu, [10]Yaoxing Huang, [11]David D Ho, [12]Peter D. Kwong, [13]Zizhang Sheng, [14]Lawrence Shapiro [Full author list]DOI: 10.1101/2021.02.21.432168 [ORCID]
PubMed: 33655245 [ORCID]
SARS-CoV-2 [missing]; SARS-CoV-2 Alpha variant [missing]; SARS-CoV-2 Beta variant [missing]; Lineage B.1.1.7 with E484K [missing]2021-02-22Yaoxing Huang (Q97650828; 8 items)
SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2[1]Shuibing Chen, [2]Liuliu Yang, [3]Benjamin E Nilsson, [4]Yuling Han, [5]Fabrice Jaffré, [6]Jiajun Zhu, [7]Pengfei Wang, [8]Tuo Zhang, [9]David Redmond, [10]Sean Houghton, ..., [18]Vasuretha Chandar, [19]Alain Borczuk, [20]Yaoxing Huang, [21]Jenny Xiang, [22]David Ho, ... [Full author list]DOI: 10.21203/RS.3.RS-94634/V1 [ORCID]
PubMed: 33236003 [ORCID]
SARS-CoV-2 [missing]2020-11-17Yaoxing Huang (Q97650828; 8 items)
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo[1]Pengfei Wang, [2]Mili R Gajjar, [3]Jian Yu, [4]Neal N Padte, [5]Agegnehu Gettie, [6]James L Blanchard, [7]Kasi Russell-Lodrigue, [8]Laura Liao, [9]Alan S. Perelson, [10]Yaoxing Huang, [11]David D Ho [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.2008190117 [ORCID]
PubMed: 32665438 [ORCID]
2020-07-14Yaoxing Huang (Q97650828; 8 items)
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids[1]Liuliu Yang, [2]Yuling Han, [3]Benjamin E Nilsson-Payant, [4]Vikas Gupta, [5]Pengfei Wang, [6]Xiaohua Duan, [7]Xuming Tang, [8]Jiajun Zhu, [9]Zeping Zhao, [10]Fabrice Jaffré, ..., [23]Vasuretha Chandar, [24]Daisy A Hoagland, [25]Yaoxing Huang, [26]Jenny Xiang, [27]Hui Wang, ... [Full author list]Cell Stem Cell [missing]DOI: 10.1016/J.STEM.2020.06.015 [ORCID]
PubMed: 32579880 [ORCID]
pluripotency [missing]; organoid [missing]; SARS-CoV-2 [missing]2020-06-19Yaoxing Huang (Q97650828; 8 items)
Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids[1]Yuling Han, [2]Liuliu Yang, [3]Xiaohua Duan, [4]Fuyu Duan, [5]Benjamin E Nilsson-Payant, [6]Tomer M Yaron, [7]Pengfei Wang, [8]Xuming Tang, [9]Tuo Zhang, [10]Zeping Zhao, ..., [16]Xing Wang, [17]Skyler Uhl, [18]Yaoxing Huang, [19]Jared L Johnson, [20]Jenny Xiang, ... [Full author list]DOI: 10.1101/2020.05.05.079095 [ORCID]
PubMed: 32511403 [ORCID]
organoid [missing]; COVID-19 [missing]2020-05-06Yaoxing Huang (Q97650828; 8 items)
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids[1]Xiaohua Duan, [2]Yuling Han, [3]Liuliu Yang, [4]Benjamin E. Nilsson-Payant, [5]Pengfei Wang, [6]Tuo Zhang, [7]Jenny Xiang, [8]Dong Xu, [9]Xing Wang, [10]Skyler Uhl, [11]Yaoxing Huang, [12]Huanhuan Joyce Chen, [13]Hui Wang, [14]Benjamin tenOever, [15]Robert E. Schwartz, [16]David. D. Ho, [17]Todd Evans, [18]Fong Cheng Pan, [19]Shuibing Chen [Full author list]DOI: 10.1101/2020.05.02.073320 [ORCID]
pluripotency [missing]; organoid [missing]; SARS-CoV-2 [missing]2020-05-03Yaoxing Huang (Q97650828; 8 items)
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids[1]Xiaohua Duan, [2]Yuling Han, [3]Liuliu Yang, [4]Benjamin E. Nilsson-Payant, [5]Pengfei Wang, [6]Tuo Zhang, [7]Jenny Xiang, [8]Dong Xu, [9]Xing Wang, [10]Skyler Uhl, [11]Yaoxing Huang, [12]Huanhuan Joyce Chen, [13]Hui Wang, [14]Benjamin tenOever, [15]Robert E. Schwartz, [16]David. D. Ho, [17]Todd Evans, [18]Fong Cheng Pan, [19]Shuibing Chen [Full author list]DOI: 10.21203/RS.3.RS-24782/V1 [ORCID]
pluripotency [missing]; organoid [missing]; SARS-CoV-2 [missing]2020-04-30Yaoxing Huang (Q97650828; 8 items)
2549 Characterizing the expression kinetics of HIV-1 envelope protein[1]Djin-Ye Oh, [2]Lihong Liu, [3]Benjamin Trinité, [4]En-Wei Hu-Van Wright, [5]Vincent Sahi, [6]Yaoxing Huang, [7]David N. Levy, [8]David D. Ho [Full author list]Clinical and translational medicine [missing]DOI: 10.1017/CTS.2018.54 [ORCID]
2018-06-01

Group #5

Matched potential author: Yaoxing Huang - author of 8 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease[1]Pengfei Wang, [2]Lihong Liu, [3]Manoj S Nair, [4]Michael T Yin, [5]Yang Luo, [6]Qian Wang, [7]Ting Yuan, [8]Kanako Mori, [9]Axel Guzman Solis, [10]Masahiro Yamashita, [11]Ankur Garg, [12]Lawrence J Purpura, [13]Justin C Laracy, [14]Jian Yu, [15]Leemor Joshua-Tor, [16]Joseph Sodroski, [17]Yaoxing Huang, [18]David D Ho [Full author list]Emerging Microbes & Infections [missing]DOI: 10.1080/22221751.2020.1823890 [ORCID]
PubMed: 32930052 [ORCID]
SARS-CoV-2 [missing]2020-09-15Yaoxing Huang (Q97650828; 8 items)
A simplified cell-based assay to identify coronavirus 3CL protease inhibitors[1]Samuel J Resnick, [2]Sho Iketani, [3]Seo Jung Hong, [4]Arie Zask, [5]Hengrui Liu, [6]Sungsoo Kim, [7]Schuyler Melore, [8]Manoj S Nair, [9]Yaoxing Huang, [10]Nicholas E S Tay, [11]Tomislav Rovis, [12]Hee Won Yang, [13]Brent R Stockwell, [14]David D Ho, [15]Alejandro Chavez [Full author list]DOI: 10.1101/2020.08.29.272864 [ORCID]
PubMed: 32869020 [ORCID]
2020-08-29Yaoxing Huang (Q97650828; 8 items)
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors[1]Sho Iketani, [2]Farhad Forouhar, [3]Hengrui Liu, [4]Seo Jung Hong, [5]Fang-Yu Lin, [6]Manoj S Nair, [7]Arie Zask, [8]Yaoxing Huang, [9]Li Xing, [10]Brent R Stockwell, [11]Alejandro Chavez, [12]David D Ho [Full author list]DOI: 10.1101/2020.08.03.235291 [ORCID]
PubMed: 32793898 [ORCID]
SARS-CoV-2 [missing]2020-08-04Yaoxing Huang (Q97650828; 8 items)

Misc

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Long intergenic non-protein coding RNA 960 regulates cancer cell viability, migration and invasion through modulating miR-146a-5p/interleukin 1 receptor associated kinase 1 axis in pancreatic ductal adenocarcinoma[1]Yaoxing Huang, [2]Qingqing Yan, [3]Danchun Yu, [4]Xiaojuan Sun, [5]Shuman Jiang, [6]Weidong Li, [7]Lin Jia [Full author list]Bioengineered [missing]DOI: 10.1080/21655979.2020.1868742 [ORCID]
PubMed: 33380238 [ORCID]
invasive ductal carcinoma [missing]; pancreatic ductal carcinoma [missing]; pancreatic ductal adenocarcinoma [missing]2020-12-30
Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study[1]Chunxia Liu, [2]Li Lv, [3]Wei Guo, [4]Lan Mo, [5]Yaoxing Huang, [6]Guocheng Li, [7]Xingzhen Huang [Full author list]BioMed Research International [missing]DOI: 10.1155/2018/6763057 [ORCID]
PubMed: 30363745 [ORCID]
pharmacokinetics [missing]; bioavailability [missing]; drug delivery [missing]2018-09-27
Characterization of rhodamine 123 low staining cells and their dynamic changes during the injured-repaired progress induced by 5-FU.[1]Yuqi Luo, [2]Haitao Yu, [3]Wentao Ou, [4]Lin Jia, [5]Yaoxing Huang [Full author list]Pathology, Research and Practice [missing]DOI: 10.1016/J.PRP.2017.04.008 [ORCID]
PubMed: 28554763 [ORCID]
2017-04-20
Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide[1]Cecilia Cheng-Mayer, [2]Yaoxing Huang, [3]Agegnehu Gettie, [4]Lily Tsai, [5]Wuze Ren, [6]Madina Shakirzyanova, [7]Silvana T Sina, [8]Nataliya Trunova, [9]James Blanchard, [10]Lisa M Miller Jenkins, [11]Yungtai Lo, [12]Marco L Schito, [13]Ettore Appella [Full author list]AIDS [missing]DOI: 10.1097/QAD.0B013E32834A1D94 [ORCID]
PubMed: 21750420 [ORCID]
2011-09-01
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification[1]Viviana Simon, [2]Veronique Zennou, [3]Deya Murray, [4]Yaoxing Huang, [5]David D Ho, [6]Paul Bieniasz [Full author list]PLOS Pathogens [missing]DOI: 10.1371/JOURNAL.PPAT.0010006 [ORCID]
PubMed: 16201018 [ORCID]
HIV [missing]2005-07-22

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Yaoxing Huangresearcher8ORCID: 0000-0001-6270-1644
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Yaoxing Huang | Author has ORCID ID:
Check VIAF for Yaoxing Huang | Author has VIAF ID:
Check ResearchGate for Yaoxing Huang | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers


Feedback
Source and documentation (at github)
Wikidata page